(Q39876164)

15 September 2017

Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol (English)

1 reference

15 September 2017

0 references

glyceryl 2-arachidonate

0 references

1 reference

9

1 reference

15 September 2017

Jenny L Wiley

8

0 references

author name string

Tiziana Bisogno

1

1 reference

15 September 2017

James J Burston

2

1 reference

15 September 2017

Ravi Rai

3

1 reference

15 September 2017

Marco Allarà

4

1 reference

15 September 2017

Bijali Saha

5

1 reference

15 September 2017

Anu Mahadevan

6

1 reference

15 September 2017

Raj K Razdan

7

1 reference

15 September 2017

1 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

4

1 reference

15 September 2017

6

1 reference

15 September 2017

946-950

1 reference

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Targeting the endocannabinoid system: to enhance or reduce?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Protective activation of the endocannabinoid system during ischemia in dopamine neurons.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Endocannabinoid control of food intake and energy balance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

The endogenous cannabinoid system controls extinction of aversive memories

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800442

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800442

1 reference

release_v36no7p2uncn3njxeoi553wg54

15 September 2017

0 references

1 reference